CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 68 enrolled
Drug / intervention
Curcumin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02494141
NCT02494141Phase 4Completed
CompareCT.gov

Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD

University of Colorado, Denver·interventional·Posted Jul 10, 2015·Updated Mar 3, 2022

In Brief

A Phase 4 clinical trial evaluating Curcumin and Placebo for Polycystic Kidney, Autosomal Dominant. Completed, enrolled 68 participants across 1 site.

Detailed Summary

The proposed research will determine the effectiveness of curcumin for improving the health and function of arteries in children and young adults with autosomal dominant polycystic kidney disease (ADPKD). The study also will provide insight into how curcumin improves artery health by determining the physiological mechanisms (biological reasons) involved and offer exploratory evidence if curcumin can slow kidney growth. This will be done by comparing these measurements in children and young adults who are randomized to receive either curcumin or placebo for 1 year.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Kidney, Autosomal Dominant
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 10, 2015
Enrollment StartNov 12, 2015
Primary CompletionFeb 1, 2021
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 11.0 years ago

Interventions

Curcumindrug

Dietary Supplement

Placeboother